In a previous exclusive interview, “Leo International Group Chairman Leo Wang: The Way of a Leader — Pursuing Business Profit While Also Changing the World!”, Leo International Group earned widespread recognition across Asia for its remarkable achievements in the luxury goods sector. Now, the company is making a bold move into the healthcare industry, with plans to launch its initial public offering (IPO) on the U.S. stock market in 2026. This expansion not only underscores the group’s ambition in the anti-aging and health management markets but also reflects its commitment to merging high-end service concepts with innovative medical solutions.
During an earlier interview, Leo Wang, Chairman and Founder of Leo International Group, spoke about how his upbringing shaped his business philosophy and life aspirations. From witnessing his mother’s dedication to philanthropy to drawing inspiration from his relatives’ successes in real estate and smart logistics, Wang also found profound influence in Wang Yung-Ching, the visionary founder of Formosa Plastics Group, particularly regarding his approach to healthcare. These experiences have guided Wang’s corporate strategy, leading Leo International Group into the health and medical sector, with a mission to leverage medical technology and global expansion to revolutionize healthcare, ultimately working toward a cancer-free future.
On January 6, 2025, Leo International Group held its OTC Market Listing Briefing in the U.S., officially announcing its biotech and healthcare division’s public listing plan. At the event, Leo Wang emphasized that since its inception, Leo International has focused on meeting the healthcare needs of Asia’s high-end market while successfully integrating biotech and medical resources across the region. The company is now concentrating on three key areas: cancer prevention, anti-aging, and holistic health management. The upcoming IPO will serve as a strategic step toward strengthening global expansion and making premium medical services more accessible.
“Business success is not just about profit; it is about creating value. At Leo International, we are committed to continuous innovation and responsible growth, merging technology with human-centric solutions to set a new global benchmark in healthcare. We firmly believe that making the world a better place is the ultimate mission of any enterprise.”
Technology and Market Perspectives From Luxury Goods to Healthcare Transformation
Leo International Group Chairman Leo Wang admitted that ever since the company entered the healthcare sector and initiated its U.S. IPO plans, his life has undergone a significant transformation. Jokingly, he remarked, “I spend all day meeting with doctors!” However, he firmly believes that these efforts are worthwhile, as healthcare is not only a major trend for the future but also a key driver in improving human quality of life. Citing Apple CEO Tim Cook’s perspective, he emphasized that Apple’s greatest contribution to humanity lies in healthcare, and Leo International aims to follow a similar path by integrating high-end services with innovative medical solutions.
Leo International Group’s healthcare division focuses on providing comprehensive solutions for anti-aging and health management. The company has introduced a strategic model to establish a satellite-based chain of anti-aging clinics, which will incorporate pre-consultation assessments, automated medical data processing, disease progression monitoring, and remote health management. The group plans to integrate artificial intelligence technology to analyze patient records and generate treatment plans swiftly, significantly enhancing the efficiency and precision of medical services. This approach is expected to drive breakthroughs in cancer prevention and treatment. By leveraging this innovative model, patient wait times can be reduced while offering a more personalized healthcare experience.
Leo Wang highlighted that the core principle of the healthcare business lies in prioritizing prevention and health management rather than solely treating existing diseases. “As the world enters an era of super-aged societies, coupled with the increasing threat of chronic illnesses such as cancer, the future of healthcare must go beyond treating diseases—it must help people live healthier, longer, and with dignity.”
Additionally, Leo International’s healthcare division plans to integrate concierge-style remote health management services to provide high-end clients with a comprehensive healthcare solution. This includes continuous health data monitoring, personalized wellness plans, and long-term follow-up services. These initiatives will incorporate smart terminal applications such as wearable devices and telemedicine platforms, ensuring seamless 24-hour connected health services.
“Our goal is to create a healthcare ecosystem driven by cutting-edge technology, offering tailored health management services for clients across all age groups. We believe this will not only benefit patients but also redefine the future of healthcare services.”
Medical Strategic Partnerships Expanding the Asia-Pacific Healthcare Landscape Through Alliances with Top Teams
Leo International Group, leveraging its expertise in high-end luxury management, is actively expanding into the healthcare sector with the goal of becoming a leader in health management across the Asia-Pacific region. The group has established medical hubs in key locations, including a medical headquarters in Taipei, a regenerative medicine center in Beijing, and a wellness center in Shanghai, with further expansions planned in Kuala Lumpur, Tahiti, and Guangzhou. These hubs not only serve as critical entry points for the group’s foray into healthcare but also act as key nodes in its effort to integrate world-class medical resources.
As a major player in Leo International’s biotech and medical division, Leo Medicare is actively expanding into major Asian cities. The company has set up large-scale flagship multi-specialty clinics, regenerative medicine centers, and international anti-aging centers in Taiwan’s seven major cities. In Shanghai, the company is introducing international wellness services, integrating medical expertise from renowned global healthcare institutions. Additionally, the group has formed a joint venture with the Malaysian publicly listed company Southeast Logistics Group, establishing a high-end anti-aging center within a private yacht marina, offering a unique model that combines premium healthcare and luxury lifestyle services. These initiatives are further enriched by Leo International’s portfolio of 1,100 international brands, adding an element of exclusivity and sophistication to high-end medical services.
Leo International has also enlisted prominent medical professionals to strengthen its expertise and leadership in the premium healthcare sector. Key figures include Dr. Chen Guang-Yao, a pioneer in radiation oncology and chairman of the Tao Sheng-Yang Anti-Cancer Foundation, Dr. Yang You-Hua, a leading oncologist and founder of the New Life Oncology Center at Taoyuan Hospital, Dr. Dai Nian-Tzu, a renowned specialist in burn treatment and professor at the National Defense Medical Center’s Department of Surgery, Dr. Chang Zhi-Hao, an expert in breast reconstruction and director of Yuzhimei International Aesthetic Clinic, and Dr. Fu Tian-Xiang, a leading authority in anti-aging and aesthetic lifting procedures. Their expertise further reinforces Leo International’s position as a leader in high-end medical services and helps shape the long-term vision for Mei’ao International’s premium healthcare initiatives.
“At the heart of precision medicine is the ability to tailor treatment plans for each individual patient, and regenerative medicine is a key technology in enhancing quality of life,” said Dr. Dai Nian-Tzu. He emphasized that stem cell technology, which repairs damaged tissues and enhances self-healing capabilities, not only effectively slows aging but also offers innovative solutions for a wide range of chronic diseases.
Continuously Accelerating Mergers, Acquisitions, and Financing to Achieve IPO and Global Expansion
Leo International Group Chairman Leo Wang has made it clear that continuous mergers and acquisitions are at the core of the group’s global expansion strategy, particularly in the technology and biotech sectors, where it seeks to acquire high-potential innovative enterprises. “Over the next five years, we plan to take multiple subsidiaries public. For example, in the field of cancer vaccine technology, we will establish independent companies for each R&D project and conduct separate IPOs. This approach will not only accelerate regulatory approval and global market entry but also help reduce costs and expand market applications.”
Currently, Leo International is not only focusing on direct investments and acquisitions in the healthcare sector but also forging strategic partnerships with internationally renowned institutions. The group has collaborated with La Prairie Switzerland to establish La Prairie Angel in Shanghai and has partnered with Anfa Medical Group, Gaoding Group’s Qiandao Lake Grande CVP International Precision Medicine Center, and Nanjing Changshougang Group to drive the development of high-end healthcare services in Asia. Additionally, the group is working closely with Swiss Olivet Shanghai, Hua’ai Medical Group, Shanghai Aidinger Plastic Surgery Hospital, and Taiwan Shangning Biotechnology to create an international, high-end, and specialized medical system, introducing advanced health management services to the Asian market.
Leo Wang emphasized that the group’s acquisition strategy extends beyond technological innovation to the diversified applications of smart healthcare. Leo International is actively investing in cutting-edge technologies that enhance medical efficiency and patient experience. By integrating artificial intelligence and big data, the company is assisting medical institutions in their digital transformation. For example, AI-powered clinical decision support systems can not only expedite emergency and critical care but also analyze patient histories to provide more precise treatment recommendations. Meanwhile, the implementation of workflow automation is optimizing hospital administrative tasks, allowing healthcare professionals to devote more time to personalized patient care.
In terms of capital market strategy, Leo International plans to gradually list different technology sectors and subsidiaries through a staged IPO process, bringing innovative companies to the public market in phases. This will attract global investment, accelerate the adoption of new medical technologies, and enhance market competitiveness. “Our goal is to leverage the capital markets to rapidly scale innovative healthcare solutions, making world-class medical services more accessible at a lower cost.”
The recent Biotech and Healthcare IPO Roadshow marks a major milestone in Leo International’s public listing strategy and signals the group’s commitment to collaborating with leading medical professionals worldwide to introduce a new service model for the healthcare industry. “We believe that through continuous innovation and global partnerships, we can provide high-end health management solutions for more Asian customers while positioning ourselves as a key player in the international healthcare market.”
At the same time, Leo International is strengthening its global reach, particularly in the rapidly developing medical technology markets of the United States, Europe, and Asia. By forging deep alliances with local partners, the group aims to establish a robust capital network and business foundation across different regions, enabling it to adapt to diverse market needs and challenges with greater agility.
Leo Wang also discussed the future direction of smart healthcare, highlighting that artificial intelligence will be the driving force behind the globalization of healthcare. AI’s ability to reduce operational costs and improve efficiency will lead to transformative breakthroughs in the industry.
“We believe that as long as we continue to innovate, maintain the highest quality standards, and strategically utilize capital markets, we will achieve a breakthrough in health management and become a key driver of the global healthcare ecosystem.”
As Leo International advances its mergers, acquisitions, and financing initiatives, it is not only solidifying its position in the healthcare sector but also establishing itself as an irreplaceable leader in global health management. Moving forward, the group will continue to drive technological adoption and global expansion through a combination of innovation and capital investment, striving to achieve both IPO success and international market leadership.
Sustainable Development Integrating Health and Social Responsibility
As the world steadily moves towards an aging society, the rising demand for health management presents both unprecedented challenges and opportunities in the medical market. Leo International Group has keenly identified this trend and is actively driving the integration of healthcare and medical technology, aiming to become a leader in the Asia-Pacific health management sector. Through innovative technology, exceptional services, and collaborations with world-class institutions, the group is developing diverse and accessible health solutions tailored to the needs of individuals across different age groups and health conditions.
Beyond technological innovation, Leo International is deeply committed to sustainable business practices and corporate social responsibility. Chairman Leo Wang emphasized, “Our goal is to make healthcare truly accessible. By reducing medical costs and improving service efficiency, we can ensure more people benefit from medical advancements, contributing to the sustainable development of global health and well-being.” This strong emphasis on social impact not only reflects Leo International’s corporate mission but also reinforces its unique value proposition in an increasingly competitive market.
With its 2026 IPO plans steadily advancing, Leo International Group is strengthening its presence in global markets. This move not only signifies an expansion of the group’s business footprint but also highlights its innovative capabilities at the intersection of luxury brand management and health technology. By leveraging its expertise in the luxury sector, the group has successfully transitioned into the healthcare industry, setting a new benchmark in the global market.
“Success in business is not just about generating profits—it is about creating value. At Leo International Group, our mission is to serve as the bridge connecting health and the future. We believe that through innovation, responsibility, and collaboration, we can truly change the world. Because making the world a better place has always been our ultimate goal.”
Recommend for you:
